Trump's Proposed 2018 Budget Will Double FDA User Fees
President Trump calls out the U.S. Food and Drug Administration for its “slow and burdensome approval process.”
Those comments came on the heels of Trump’s roundtable with drug company CEOs in the White House Roosevelt Room, during which he assured that “[w]e’re going to streamline the FDA ... and you’re going to get your products either approved or not approved but it’s going to be a quick process. It’s not going to take 15 years.” Download this white paper to continue reading ...
Jason Drori is a senior counsel in the Business Litigation & Dispute Resolution Practice of Foley & Lardner LLP. Mr. Drori concentrates his practice on the legal needs, business challenges, and regulatory pressures of the life sciences sector, particularly pharmaceuticals.
David L. Rosen
Foley & Lardner LLP
David Rosen is a partner and public policy lawyer with Foley & Lardner LLP. Mr. Rosen has extensive experience in health law, life sciences, and food and drug regulation, including a range of Food and Drug Administration (FDA) regulatory issues affecting prescription and over-the-counter pharmaceuticals, medical devices and biologics.
All of your training, right here at Lorman.
Pay once and get a full year of unlimited training
in any format, any time!
White Papers and Articles
Sponsored Live Webinars
Additional benefits include:
State Specific Credit Tracker
Members Only Newsletter
All-Access Pass Course Concierge
* For audio recordings you only pay shipping
Questions? Call 877-296-2169 to speak with a real person.
You can Login to access if you are already registered.